Therapies for posterior uveitis are limited to corticosteroids, cyclosporine and tumour necrosis factor (TNF)-blocking agents as well as off-label use of methotrexate, azathioprine and mycophenolates [2,3]. This evidence concerns the gene TNF and posterior uveitis.